Summary: As part of the new Pharma Leaders Today series, Allen E. Norris, Vice President and Head Group IP at UCB Pharma, speaks to Andrea Charles from Pharma IQ, about current trends in biopatents and how pharma companies can readdress the imbalance between new product
